Comparative Pharmacokinetics of Kanamycin between Multi-drug Resistant Tuberculosis Patients and Healthy Volunteers

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.15640/IJMP.V2N2A4
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• 1 INTRODUCTION TO PHARMACOKINETICS AND PHARMACODYNAMICS

  2016cited by this paper
• Prevalence and risk factors associated with drug resistant TB in South West, Nigeria.

  2011cited by this paper
• Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis.

  2010cited by this paper
• The Population Dynamics and Control of Tuberculosis

  2010cited by this paper
• Population Pharmacokinetics of Arbekacin in Patients Infected with Methicillin-Resistant Staphylococcus aureus

  2006cited by this paper
• Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases.

  2004cited by this paper
• Modeling the emergence of the 'hot zones': tuberculosis and the amplification dynamics of drug resistance

  2004cited by this paper
• Hearing loss and nephrotoxicity treatment in patients with in long-term aminoglycoside tuberculosis

  2002cited by this paper
• Hearing loss and nephrotoxicity in long-term aminoglycoside treatment in patients with tuberculosis.

  2002cited by this paper
• Smoking and tuberculosis: an association overlooked.

  2002cited by this paper
• Pharmacokinetics of intramuscularly administered aminosidine in healthy subjects

  1997cited by this paper
• Cigarette smoking as a risk factor for tuberculosis in young adults: a case-control study.

  1996cited by this paper
• Serum gentamicin assay: A comparison and assessment of different methods

  1974cited by this paper
• Comparative pharmacokinetics of amikacin and kanamycin

  1974influential reference

• Plant-derived Molecules for the Treatment of Tuberculosis: A Review

  2022cites this paper
• Rates and risk factors for nephrotoxicity and ototoxicity among tuberculosis patients in Tbilisi, Georgia.

  2019cites this paper
• Biofilm infections between Scylla and Charybdis: interplay of host antimicrobial peptides and antibiotics

  2018cites this paper